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 Previous studies from our laboratory have defined a small
membrane protein that regulates glial cell proliferation in re-
sponse to injury [1] and in brain development [2]. Neither the
specific functions nor molecular associations of CD81 are fully
understood. In an effort to characterize CD81 fully, we have
turned to the developing retina, which offers a unique oppor-
tunity to study the expression and developmental interactions
of this small membrane protein. CD81 is expressed by Müller
glial cells [3] and RPE cells [2]. In rodents, both of these cell
types exit the cell cycle after birth [4-6]. Specifically, retinal
pigment epithelium (RPE) cells divide up to two weeks, and
Müller cells until 14-22 days after birth [5]. Furthermore, both
cell types are restricted in the well-characterized laminar struc-
ture of the retina, allowing relatively simple anatomical char-
acterization of protein distribution. If CD81 is involved in the
final stages of maturation of RPE cells and Müller cells, we
can examine its developmental expression pattern relative to
that of other proteins co-expressed or associated with CD81.
CD81, like other members of the tetraspanin family of
proteins, is a small membrane protein with four transmem-
brane segments, two small extracellular loops, and small in-
tracellular N and C terminal domains. Tetraspanins form rela-
tively large molecular complexes, called tetraspanin webs,
within the plane of the membrane [7-9]. At present, many dif-
ferent membrane proteins can be present within these com-
plexes, including the 12 different mammalian tetraspanins that
are known to interact with at least 38 different transmembrane
proteins [10-13]. The specific function of the tetraspanin com-
plexes appears to depend on the district proteins forming the
complex and the cells in which they are expressed. For ex-
ample, CD81, through its association with integrin adhesion
molecules, can be critically important for cell adhesion and
migration [14-19]. These tetraspanin complexes link extra-
cellular events to intracellular signaling cascades [20-24].
When CD81/tetraspanin forms a complex with integrins, it
modulates the cells interactions with the extracellular matrix
[25-27] through activation of second-messenger systems
[23,28,29].
There is a general lack of knowledge about how these
proteins link into intracellular processing and second messen-
ger cascades. Examination of the intracellular domains of the
tetraspanin family members reveals that CD81 is unique in
that it carries a potential PDZ binding domain. At the intracel-
lular C-terminal end of CD81, the sequence SSVY appears;
this sequence is similar to a PDZ binding domain [30-32].
Like the tetraspanins, PDZ-containing proteins typically are
associated with large complexes of proteins performing local-
ized signaling functions. In the present study, we examined
the interactions of CD81 with PDZ proteins in the developing
rat retina. Our overall goals were to define the molecular in-
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181teractions of CD81 with PDZ target proteins and to determine
the temporal regulation and distribution of CD81 and PDZ
targets in the retina. Since RPE expressed high levels of CD81,
we focused on it as well as two PDZ proteins, synapse-associ-
ated protein 97 (Sap97) and ezrin-radixin-moesin-binding
phosphoprotein 50 (EBP50), which are spatially segregated
[33].
METHODS
Association of CD81 with intracellular proteins:  To examine
the putative PDZ binding domain on the intracellular, C-ter-
minal end of CD81, we used a modification of a commer-
cially available protocol developed by Panomics (Redwood
City, CA). We produced a peptide, H-Gly-Lys-Pro-Ile-Pro-
Asn-Pro-Leu-Leu-Gly-Leu-Asp-Ser-Thr- Leu-Cys- Cys-Gly-
Ile-Arg-Asn-Ser-Ser-Val-Tyr-OH, containing the C-terminal
end of CD81 with its putative PDZ binding domain (in blue
color). To allow detection of this peptide in assays, we incor-
porated the epitope tag for the anti-V5 antibody (red). We also
synthesized two control peptides. One had a scrambled amino
acid sequence H-Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-Leu-Gly-
Leu-Asp-Ser-Thr- Tyr-Val- Ser-Ser-Arg-Asn-Ile-Gly-Cys-
Cys-Leu-OH; the other contained the C-terminal, intracellu-
lar portion of CD81 minus the putative PDZ binding domain
H-Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-Leu-Gly-Leu-Asp-Ser-
Thr- Leu-Cys- Cys-Gly-Ile-Arg-Asn-OH.
We purchased dot blots of glutathione S-transferase (GST)
fusion proteins representing all of the known PDZ sequences
from Panomics. We probed these blot dots with the experi-
mental peptide and immunostained them with the V5 anti-
body, which is amouse monoclonal antibody tagged with horse-
radish peroxidase (HRP; Invitrogen, Carlsbad, CA) then pro-
cessed them according to the manufacturer’s suggested proto-
col. To monitor chemiluminescence, we placed the blots in
the supplied detection buffer and scanned them using a Ty-
phoon 8600 Scanner (Molecular Dynamics). We then analyzed
the blots to determine if there were sequence-specific binding
to any of the GST fusion proteins, which represented 29 dif-
ferent PDZ domains (Redwood, CA). A total of six Panomic
dot blots were run, two for each peptide.
Antibodies:  The antibody directed against rat CD81 was
AMP1, developed in our laboratory [1]. Other antibodies were
rabbit anti-Sap97 (Affinity BioReagents, Golden, CO), rabbit
anti-EBP50 (Affinity BioReagents), mouse anti-CD71, the
transferrin receptor (Chemicon, Temecula, CA), and rabbit
anti-Ezrin (Santa Cruz Biotechnology, Santa Cruz, CA). Sec-
ondary antibodies were either labeled with fluorescent mark-
ers or HRP. Peroxidase antibodies used were donkey anti-rab-
bit or donkey anti-mouse IgG (Jackson ImmunoResearch, West
Grove, PA). Fluorescence-labeled secondary antibodies in-
cluded rhodamine-labeled donkey anti-rabbit (Jackson
ImmunoResearch), Alexa 568 goat anti-rabbit (Molecular
Probes, Eugene, OR), and Alexa 488 donkey anti-rabbit (Mo-
lecular Probes).
Isolation of proteins associated with CD81 from cultured
retinal pigment epithelium:  We used Long-Evans rats for tis-
sue-culture experiments to determine the presence of pigment
aided in dissections and culturing. RPE cells were cultured
using the method of Edwards [34]. In brief, we removed the
eyes from rat pups 6 to 8 days of age and placed them in bal-
anced salt solution with 0.3 mM CaCl2 for 2-3 h at room tem-
perature in the dark. We placed the globes in 1 mg/ml of trypsin
in Hank’s balanced salt solution (HBSS) plus 70 units of col-
lagenase (pH 7.8) for 45 min at 37 °C. We then transferred the
eyes to medium with 20% fetal calf serum (FCS) and antibi-
otics and removed the anterior chamber by cutting through
the sclera and neural retina just behind the ora serrata. We left
the posterior chamber in medium so that the retina expanded,
separating from the underlying pigment epithelium. We gen-
tly removed the RPE from Bruch’s membrane and place it in
sheets of RPE in HBSS/EDTA plus 0.1% trypsin for 5 min.
We rinsed the disassociated cells and transferred them to a
T25 flask. Confluent cultures of rat RPE were rinsed three
times in cold 0.01 M phosphate buffered saline (PBS), pH
7.4. We lysed the cells in ice-cold 1% Brij 97 in 0.05 M Tris
and 0.05 M NaCl, pH 7.3, containing NaN3 and
phenylmethylsulphonyl fluoride (PMSF), then centrifuged at
15,000 x g for 90 min at 4 °C. CD81 and the associated pro-
teins were co-isolated by immunoprecipitation with the AMP1
antibody. We placed the proteins in nonreducing sample buffer,
separated them by SDS PAGE, transferred them to nitrocellu-
lose, and blotted with antibodies directed against Sap97,
EBP50, and Ezrin.
Immunoblot analysis:  We used one litter of 12 Sprague-
Dawley rat pups for the immunoblot analysis. For pups taken
before P15, we used hypothermia as anesthesia and decapi-
tated the pups. The mother was anesthetized by intraperito-
neal injection of a mixture of xylazine (13 mg/kg, Rompun)
and ketamine (87 mg/kg, Ketalar), and her eyes were used as
the adult sample. After the animals were sacrificed, their eyes
were removed. We dissected the retinas and placed them in
nonreducing sample buffer (2% SDS and 10% glycerol in 0.05
M Tris-HCl buffer, pH 6.8). To analyze the concentrations of
CD81 in the retina, we used gel electrophoresis and
immunoblot methods, similar to those described in Geisert
[2]. Using balanced samples of proteins from the retina, we
ran them in 4% to 16% acrylamide gels, then transferred them
to nitrocellulose. The blots were blocked with 5% nonfat dry
milk in borate buffer (pH 8.4) and probed overnight with the
primary antibody, AMP1, or anti-EBP50. We then rinsed the
blots and probed them with the secondary antibody, HRP-la-
beled goat anti-mouse. The blots were rinsed with 0.5 M Tris
buffer (pH 7.4) and reacted with 0.05% DAB and hydrogen
peroxide.
Immunohistochemistry:  We used one litter of 11 postna-
tal Sprague-Dawley rat pups and the mother in our immuno-
histochemical analysis of the retina, taking at least two pups
at each developmental age: P0, P2, P10, P15, or P20. The
mother was used as the adult sample. For the pups taken be-
fore P15, we used hypothermia as anesthesia and perfused the
pups. The P20 pups and the mother were anesthetized by in-
traperitoneal injection of a mixture of xylazine (13 mg/kg,
Rompun) and ketamine (87 mg/kg, Ketalar) and perfused
through the heart with a saline solution followed by 4%
©2007 Molecular Vision Molecular Vision 2007; 13:181-9 <http://www.molvis.org/molvis/v13/a21/>
182paraformaldehyde in 0.1 M phosphate buffer (pH 7.3). After
administering the anesthesia, we removed the eyes and placed
them in 4% paraformaldehyde overnight. The next day, we
transferred the eyes to 30% sucrose for a minimum of 2 days.
We cut 16 µm sections of the eyes on a cryostat and placed
them on glass slides. The methods used to stain the retina were
similar to those previously described [2]. The slides were rinsed
in 0.02 M PBS (pH 7.3), placed in 4% BSA containing 0.05%
DMSO, and probed overnight with the primary antibody,
AMP1 (1:100). After rinsing, we added a donkey anti-mouse
secondary antibody (1:200) for 2 h then rinsed the slides in
three changes of 0.05 M Tris (pH 7.3). To determine if the
CD81 associated with Sap97 or EBP50, we used double-label
immunohistochemistry similar to that described in Clarke and
Geisert [3]. We first stained the retina with the anti-rat CD81,
then added a rabbit antiserum directed against Sap97 or EBP50.
The fluorescent-tagged secondary antibodies had been made
in donkey and preabsorbed against serum proteins to prevent
cross reactivity.
RESULTS
 The present study began with the observation that CD81 con-
tains a potential PDZ binding domain at its intracellular C-
terminus, the amino acid sequence Ser-Ser-Val-Tyr. As a first
step in our analysis of the ability of CD81 to interact with
PDZ domains, we used synthetic peptides to identify interact-
ing PDZ domains on a dot blot constructed with GST fusion
proteins. The first peptide was identical to the C-terminus of
CD81; the second was a control peptide missing the putative
PDZ binding domain; the third was a control peptide with a
scrambled amino-acid sequence. We used the peptides in an
overlay assay probing GST-fusion proteins representing dif-
ferent types of PDZ domains. When the blots were analyzed,
three different types of PDZ domains bound specifically the
C-terminal sequence of CD81 and not to control peptides (Fig-
ure 1). One PDZ domain belonged to Sap97. The second and
third sets of spots that bound to CD81 peptide represented a
PDZ domain type 1. This finding suggested not only that the
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Figure 1. Binding of C-terminal peptides to PDZ domains.  The bind-
ing of synthetic peptides to dot-blotted GST fusion proteins repre-
senting PDZ domains. Lane 1: a peptide that models the C-terminus
of CD81 Lane 2: a peptide without the putative PDZ binding do-
main. Lane 3: the binding of a scrambled protein. Specific binding
was observed for the Sap97 domain 3, the protein-tyrosine phos-
phatase domain 1 (PTP-D1), and the X11L2 protein domain 1 (Mint-
D1). Each PDZ domain is spotted with two concentrations of pro-
tein: 400 ng (upper spot) and 80 ng (lower spot). GST represents
glutathione S-transferase.
Figure 2. Proteins associated with CD81.  Cultured rat retinal pig-
ment epithelium (RPE) cells were solubilized in 1% Brij 97 and im-
munoprecipitated with mouse anti-rat CD81 antibody. The sample
of proteins was then separated by SDS PAGE, transferred to nitro-
cellulose, and probed with antibodies directed against CD81 (lane
A), EBP50 (lane B), Ezrin (lane C), and Sap97 (lane D). Note that
CD81 coimmunoprecipitated with EBP50, Ezrin, and Sap97. In con-
trol experiments, antibodies directed against the transferrin receptor
(CD71) were used to immunoprecipitate proteins from cultured RPE.
When these samples were probed for EBP50 (lane E) or Sap97 (lane
F), these two PDZ proteins were not observed. Molecular weight
markers are indicated to the left in kDa.
Figure 3. Quantitative changes in CD81 and EBP50.  The develop-
mental regulation of EBP50 and CD81 is shown for different devel-
opmental ages: postnatal day 0 (P0), P2, P10, P15, P20, and adult. At
P0, scant EBP50 and CD81 are present in the retina. There is a gradual
increase until P20, when almost adult levels are observed. The levels
of these two proteins do not completely mirror each other. EBP50 is
expressed only in the microvilli of the retinal pigment epithelium
cells, and CD81 is expressed throughout the entire retina.
183C-terminal end of CD81 was a PDZ binding domain, but that
the C-terminal end bound to a subset of PDZ proteins, Sap-97
and the Domina 1 of Mint and PTP.
The next step was to determine if the proteins expressed
by RPE cells contained any of these PDZ domains. We
searched our microarray data from RPE cells [35] and con-
sulted the literature [33]. Two candidate proteins were imme-
diately obvious, Sap97 and EBP50, both expressed at high
levels in RPE. Sap97 and EBP50 contain all of the types of
PDZ domains labeled by the CD81 C-terminal peptide.
To directly test for the binding of CD81 to Sap97 and
EBP50, we did a series of immunoprecipitation studies. For
these studies, we solubilized cultured rat RPE with a mild de-
tergent, then precipitated complexes of proteins associated with
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Figure 4. Colocalization of CD81 with Sap97 and EBP50 in the developing retinal pigment epithelium layer.  The developmental pattern of
expression of Sap97 (A, D, G, J), EBP50 (M, P, S, V), and CD81 (B, E, H, K, N, Q, T, W) is shown for the retinal pigment epithelium (RPE)
cell layer in double-stained sections at different developmental ages: P0 (A-C, M-O), P2 (D-F, P-R), P10 (G-I, S-U), and P15 (J-L, V-X). The
merged images are shown to the right (C, F, I, L, O, R, U, X). At P0 (A-C, M-O) CD81 levels are low, with only a faint outline of the
developing RPE. There is little immunostaining for Sap97 (A) or EBP50 (M). By P2 (D-F, P-R), CD81 defined the cellular membranes of the
RPE cells. There is a clear upregulation of Sap97 along the basal surface of the RPE (D, arrow). Sap97 is distributed on the basolateral surfaces
of the RPE cells (F). The levels of EBP50 are also increasing (P), forming a tight band of immunoreactivity at the junction between the RPE
cells and the developing photoreceptors (arrow). EBP50 immunoreactivity labels the apical surface of RPE cells (R). The levels of all three
proteins increase over time, and the immunolabeling pattern becomes more distinct at P10 and P15. All photomicrographs were taken at the
same magnification. In the scale bar, X=25 µm.
184CD81, using antibodies against CD81 attached to Sepharose
beads (Figure 2). As expected, a variety of proteins were pre-
cipitated along with CD81. To test for both Sap97 and EBP50
among these proteins, we conducted a cross-blotting experi-
ment. We separated the precipitated proteins on SDS PAGE
gels, transferred them to nitrocellulose, and probed the blots
with antibodies directed against CD81 (Figure 2A), EBP50
(Figure 2B), and Sap97 (Figure 2D). These protein bands were
not observed with similar protein samples immunoprecipitated
with control mouse IgG (data not shown) or with antibodies
against CD71, the transferin receptor (Figure 2E,F). These
results demonstrate that CD81 is specifically associated with
both Sap97 and EBP50. Since there is a strong association
between EBP50 and Ezrin [33,36], we also probed the immu-
noprecipitated proteins with anti-Ezrin antibodies, observing
a strong band (Figure 2C). These results demonstrate a direct
link between any tetraspanin (CD81) and an intracellular sig-
naling pathway (Sap97 and EBP50), linking a tetraspanin com-
plex into the cytoskeleton through Ezrin and potentially into
second-messenger cascades.
To further explore the relationship between CD81 and
these PDZ proteins, we examined the levels of CD81 and
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Figure 5. Colocalization of CD81 with Sap97 and EBP50 at P20.  The staining of the P20 rat retina for CD81 (A and D), Sap97 (B), and EBP50
(E) is shown in two double-stained sections. The merged images of these two sections are shown in C and F. The pattern of CD81 labeling is
consistent with the labeling of Müller glial cells, as shown by the prominent labeling of the external limiting membrane (arrow, A) and retinal
pigment epithelium (RPE) cells (double arrow, A). Sap97 shows a general stain in the retinal neurons and a prominent band at the base of the
RPE (arrow in B). In the merged image (C), Sap97 immunoreactivity is colocalized with CD81 on the basolateral surface of RPE cells. EBP50
labels a prominent band at the junction between the retina and the PRE cells (arrow, E). The EBP50 immunoreactivity colocalizes with CD81
immunoreactivity at the apical surface of the RPE cells (F). In A and F, the layers of the P20 retina are shown: the ganglion cell layer (GCL),
inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), and outer nuclear layer (ONL). All photomicrographs are
taken at the same magnification. The scale bar in F represents 25 µm.
185EBP50 in the developing retina, running a series of
immunoblots on samples of retina taken at different postnatal
time points (Figure 3). At P0, we found a faint but distinct
band at 27 kDa, indicating that the levels of CD81 were low.
Over the next few days, the levels of CD81 gradually increased,
and by P20, CD81 was close to that of the adult level. We then
quantified the protein levels in the retina relative to that ob-
served in the adult, using the intensity of the 27 kDa band in
three protein samples from individual eyes to determine the
relative levels of CD81. We found that the levels of CD81 at
P0 were 31% of the adult level. There was increased intensity
of the immunopositive band, and at P15, the levels were ap-
proximately 85% of that in the adult. We did not measure the
levels of Sap97 because its expression is dominated by synap-
tic formation in the retina relative to the low levels observed
in the RPE cell layer. We did measure the levels of EBP50
because this protein is almost exclusively expressed in the RPE
cells (Figure 3). We found, as with CD81, that the levels of
EBP50 were low at P0 but high by P20. Thus, in addition to
the dramatic upregulation of CD81 during postnatal develop-
ment of the retina, at least one PDZ, EBP50, follows the same
pattern.
We extended this analysis by looking at the change in the
developmentally regulated immunolabeling pattern in the RPE
cell layer at closely spaced postnatal developmental time points
(Figure 4). In the developing retina, the RPE layer is adjacent
to the outer edge of the retina next to future photoreceptor
layer. At P0 (Figure 4A-C, Figure 4M-O), there is little
immunolabeling for Sap97 (Figure 4A), CD81 (Figure 4B,N),
or EBP50 (Figure 4M). By P2, all proteins begin to increase
in expression and reveal a distinctive pattern of labeling, with
Sap97 at the basal surface of the developing RPE cells (Fig-
ure 4D, arrow) and EBP50 at the dorsal inner surface of these
cells (Figure 4P, arrow). The labeling on the inner surface ap-
pears to mark the emerging microvilli on the RPE that eventu-
ally will surround the outer segments of the photoreceptors.
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Figure 6. Colocalization of CD81 with Sap97 and EBP50 at P2.  The staining pattern of CD81, Sap97, and EBP50 in the developing rat retina
is shown at P2. A and D are stained for CD81, B is stained for Sap97, and C is the merged image. E is stained for EBP50; F is the merged
image. At this age, the ganglion cell layer (GCL) and inner plexiform layer (IPL) are present. The remainder of the retina consists of a
neuroblastic layer (NBL). The arrows in B and E indicate the location of the developing retinal pigment epithelium (RPE) layer. All photomi-
crographs were taken at the same magnification. The scale bar in represents 25 µm.
186This pattern continues to emerge until by P20 the adult pat-
tern is observed. For Sap97, the antibody is localized to the
dorsal lateral and ventral surfaces of the RPE cells (Figure
5B). EBP50 is diametrically apposed, selectively labeling the
microvilli on the inner surface of the RPE cells (Figure 5E).
Both of these intracellular proteins appear to be colocalized
with CD81, forming two distinct molecular groupings: one
on the basolateral surface of the RPE cells (Figure 5C) and
the other on the inner surface of the RPE cells (Figure 5F).
We next focused on the general pattern of CD81, EBP50
and Sap97, at two time points, P2 (Figure 6) and P20 (Figure
5). The first distinct pattern of labeling in the retina is seen at
P2, when there was light generalized labeling for CD81 (Fig-
ure 6A,D). The ganglion layer had the highest levels of CD81
immunoreactivity, which outlined groups of cell bodies. The
next highest level of CD81 labeling was in the inner plexi-
form layer with light labeling around the undifferentiated
neuroblasts that make up the majority of retinal cells in the P2
retina. In addition, there was relatively prominent labeling of
the developing blood vessels in the inner retina. The pattern
observed at P2 provides the first indication of specific label-
ing by Sap97and EBP50. Sap97 labeling appeared in the de-
veloping RPE cell layer (Figure 6B) and was strongly associ-
ated with CD81 at the base of these cells (Figure 6C). In the
developing retina, EBP50 labeled a prominent band in the
developing retina (Figure 6E) that is associated with the inner
surface of the developing RPE cell layer (Figure 6F).
The pattern of labeling at P20 was similar to that observed
in the adult retina and was suggestive of labeling of Müller
cells and astrocytes (Figure 5A,D). There was prominent la-
beling of the retina from the internal limiting membrane to
the outer limiting membrane. In addition, the inner limiting
membrane was clearly labeled. This pattern is similar to that
which we previously described (Clarke and Geisert 1998) [3].
The prominent labeling of the external limiting membrane and
increased immunoreactivity around blood vessels, especially
in the ganglion cell layer, was indicative of labeling of Müller
glial cells and astrocytes in the ganglion cell layer.
DISCUSSION
 Previous study of the developing brain and spinal cord [14]
demonstrated that CD81 is upregulated at approximately the
same time that glial cells exit the cell cycle. A similar tempo-
ral pattern of expression was observed in the developing retina.
CD81 is expressed by Müller glial cells [3] and RPE cells [2].
In the postnatal retina [4,5], cells of the RPE actively divide
through P7 [6]; Müller cells proliferate up to P22 [5]. During
the end of mitotic activity, we observed a significant increase
in the levels of CD81 as well as patterns of expression consis-
tent with CD81 being expressed by RPE cells and Müller cells.
The fact that CD81 is upregulated at the specific time these
cells stop dividing indicates that this protein has a critical func-
tion in the final stages of development, maturation, and nor-
mal function of the adult retina.
This study has allowed us to examine CD81 and its po-
tential intracellular interactions in RPE cells, for these cells
develop postnatally and represent a well-characterized epithe-
lium. In general, CD81 and other members of the tetraspanin
family participate in a wide variety of molecular complexes.
These associations of CD81 with different membrane proteins
result in molecular complexes, representing diverse
microdomains within the cell membrane. CD81 forms a com-
plex with CD19 and CD21 in the mnemonic response of B
cells [9,24,37]. In addition, CD81 is critical for cell adhesion
and migration through its association with adhesion molecules
[14-19]. In both cases, the tetraspanin complexes link extra-
cellular events to intracellular signaling cascades [20-24].
These links are revealed by antibody binding to CD81 that
activates a tyrosine kinase in human lymphocytes [22,23,28].
By partnering with different membrane proteins, CD81
is involved in a variety of different cellular functions
[15,18,22,38,39]. For example, when CD81 forms a complex
with integrins, it is directly involved in regulating cellular in-
teractions with the extracellular matrix [25-27]. This interac-
tion has a defined effect on second-messenger systems
[23,28,29] and, eventually, modulates the mitotic activity of
the cell [1,40,41].
Given all that we know about tetraspanin interactions with
membrane proteins, there remains a distinct lack of informa-
tion about the linkage of the tetraspanin complexes into intra-
cellular compartments. Recently, Sala-Valdes et al. [13] dem-
onstrated linkage of CD9 directly to Ezrin protein. This inter-
action links EWI-2 and EWI-F proteins, along with CD81,
directly to actin through the CD9/Exrin complex to the actin
cytoskeleton. Like the complex observed by Sala-Valdes et
al. [13], CD81 in the RPE cells is associated with E EWI-2,
EWI-F, CD9, b1 integrin, a3 integrins, and a5 integrin [42].
Furthermore, the RPE cells allows us one of the first glimpses
into the potential linkage of tetraspanin complexes through
CD81 into intracellular components.
We found that the amino acid sequence on the C-terminal
end of CD81 appeared to have the ability to bind a PDZ bind-
ing domain. When we tested synthetic peptides of the C-ter-
minal domain against GST fusion proteins, we observed that
the peptide specifically bound to three spots on the Panomic
dot blot. The Sap97 spots represent the PDZ domain 3 of
Sap97. Examination of microarray data from RPE cells [35]
revealed that the most likely candidates were Sap97 and
EBP50. EBP50 has two PDZ domains, including PDZ domain
1 [36]. Immunoprecipitation studies confirmed an association
among CD81, Sap97, and EBP50.
In adult rats, we found CD81 on all surfaces of the RPE
cells [2], while EBP50 was associated with microvilli on the
inner surface and Sap97 was on the basolateral surface of the
cells [33]. Upregulation of all three proteins followed approxi-
mately the same time course. As RPE cells mature, these pro-
teins occupy their specific subcellular localizations and, pre-
sumably, carry out their adult functions. Due to the distinct
locations of these two PDZ proteins within the RPE, CD81
must be involved in at least two different molecular complexes,
one in the microvilli associated with EBP50/Ezrin and the other
associated with Sap97 on the lateral and basal cell surfaces.
Indeed, this is what we found. On the apical surface of the
cells, CD81 is associated with EBP50, and these proteins are
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187upregulated on a similar time course as the RPE matures.
What are the specific functional roles of each of the CD81/
tetraspanin complexes? At present, we do not know the spe-
cific molecular components of each complex. However, we
do know that CD81 is associated with EBP50 on the inner
RPE microvilli. Recent studies [43,44] have found that EBP50
is associated with cellular retinaldehyde-binding protein
(CRALBP). This molecular interaction localizes CRALBP to
the precise subcellular compartment where the shed outer seg-
ments of rods are ingested by the RPE and where retinoid
processing occurs. It is tempting to speculate that the PDZ
protein EBP50 links the CD81 complex in the microvilli to
CRALBP. If the CD81/EBP50 complex is associated with the
ingestion of shed outer rod segments, this association through
EBP50 would bring the molecular machinery for retinoid pro-
cessing into direct association with the shed outer rod seg-
ments.
We  also found CD81 colocalized with Sap97 on the
basolateral surface. Immunohistochemical examination
showed a similar upregulation during early postnatal devel-
opment. One could speculate that CD81 associated with Sap97
on the basolateral surface of cells has an important function in
the final stages of RPE cell development and the stabilization
of cellular contacts. In the postnatal retina, RPE cells and
Müller cells continue to divide until the appropriate number
of cells is reached. In the final stages of retinal development,
these two cell types downregulate their cell cycles and enter
G0 [4,6]. The stopping of proliferation and the attainment of
final maturation are developmental consequences of differen-
tiation. After injury of the adult retina, these two cell types
can reenter S phase and proliferate again [45,46], frequently
resulting in the formation of cellular membranes termed pro-
liferative vitreoretinopathy [47-50]. These membranes can
contract, causing the retina to detach.
In our effort to understand the molecular mechanism gov-
erning the regulation of glial proliferation and reactivity, we
focused on a member of the tetraspanin family of proteins,
CD81. This tetraspanin was originally termed the target of an
antiproliferative antibody [40], since antibodies directed
against CD81 depressed the mitotic activity of cultured cells.
A considerable amount of experimental findings indicate that
CD81 is part of one of the molecular mechanisms regulating
the cell cycle as well as cell migration [9,11,41]. When the
normal stabilizing functions of CD81 are disrupted, as in pho-
toreceptor cell death, the complex may signal to the cell to
begin migrating and dividing again. We currently are pursu-
ing further studies of the function of CD81 following injury.
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